Kestra Advisory Services’s BioNTech BNTX Stock Holding History

Kestra Advisory Services’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,046	Closed	-$307K	–	2092
2022 Q4	$307K	Buy	+2,046	New	+$315K	﹤0.01%	1728
2022 Q2	–	Sell	-1,322	Closed	-$225K	–	2141
2022 Q1	$225K	Sell	1,322 -5,568	-81%	-$936K	﹤0.01%	1772
2021 Q4	$1.78M	Buy	6,890 +219	+3%	+$60K	0.02%	729
2021 Q3	$1.82M	Buy	6,671 +5,750	+624%	+$1.83M	0.02%	754
2021 Q2	$206K	Buy	+921	New	+$174K	﹤0.01%	1849
2021 Q1	–	Sell	-2,821	Closed	-$237K	–	1868
2020 Q4	$237K	Buy	+2,821	New	+$277K	﹤0.01%	1610

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Kestra Advisory Services's BNTX Position: Q1 2023 in Review

Kestra Advisory Services sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 2,046 shares — an estimated $307K sold.

Kestra Advisory Services first reported a position in BNTX in Q4 2020 and held it in 6 quarters. The position peaked at $1.82M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

Kestra Advisory Services reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
Kestra Advisory Services sold 2,046 BioNTech shares in Q1 2023, an estimated $307K.
Kestra Advisory Services first reported a position in BioNTech in Q4 2020 and held it in 6 quarters.
Kestra Advisory Services's BioNTech position peaked at $1.82M in Q3 2021.
282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Kestra Advisory Services's 13F filing for Q1 2023, filed 12 May 2023.